Journal home
Advance online publication
Current issue
Archive
Press releases
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews Immunology
Nature Medicine
Nature Cell Biology
NI Tutorial: Finding regulatory DNA regions
Signaling Gateway
Immunology & Cell Biology
Mucosal Immunology
Nature Conferences
Nature Stem Cells
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Immunology  4, 920 - 927 (2003)
Published online: 17 August 2003; | doi:10.1038/ni968

SIGIRR, a negative regulator of Toll-like receptor−interleukin 1 receptor signaling

David Wald1, Jinzhong Qin1, Zhendong Zhao1, Youcun Qian1, Mayumi Naramura1, Liping Tian1, Jennifer Towne2, John E Sims2, George R Stark1 & Xiaoxia Li1

1  Cleveland Clinic Foundation, Department of Immunology, Cleveland, Ohio 44195, USA.

2  Amgen Corporation, 51 University Street, Seattle, Washington 98101, USA.

Correspondence should be addressed to Xiaoxia Li lix@ccf.org
The Toll-like receptor−interleukin 1 receptor signaling (TLR−IL-1R) receptor superfamily is important in differentially recognizing pathogen products and eliciting appropriate immune responses. These receptors alter gene expression, mainly through the activation of nuclear factor-kappaB and activating protein 1. SIGIRR (single immunoglobulin IL-1R-related molecule), a member of this family that does not activate these factors, instead negatively modulates immune responses. Inflammation is enhanced in SIGIRR-deficient mice, as shown by their enhanced chemokine induction after IL-1 injection and reduced threshold for lethal endotoxin challenge. Cells from SIGIRR-deficient mice showed enhanced activation in response to either IL-1 or certain Toll ligands. Finally, biochemical analysis indicated that SIGIRR binds to the TLR−IL-1R signaling components in a ligand-dependent way. Our data show that SIGIRR functions as a biologically important modulator of TLR−IL-1R signaling.

MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

REFERENCE
Septicaemic Shock
Nature Encyclopaedia of Life Sciences
 See all 3 matches for Reference

REVIEWS
Tumor necrosis factor receptor-associated factors (TRAFs)
Oncogene Reviews (02 Oct 2001)
 See all 22 matches for Reviews

NEWS AND VIEWS
SIGIRR puts the brakes on Toll-like receptors
Nature Immunology News and Views (01 Sep 2003)
Innate and acquired activation pathways in T cells
Nature Immunology News and Views (01 Feb 2001)
 See all 11 matches for News And Views

RESEARCH
TRAM is specifically involved in the Toll-like receptor 4–mediated MyD88-independent signaling pathway
Nature Immunology Article (01 Nov 2003)
 See all 38 matches for Research

 Top
Abstract
Previous
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

naturejobs

Figures & Tables
See also: News and Views by O'Neill
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Immunology
ISSN: 1529-2908
EISSN: 1529-2916
Journal home | Advance online publication | Current issue | Archive | Press releases | Focuses | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2003 Nature Publishing Group | Privacy policy